NEXI - NexImmune, Inc. Stock Price, Fair Value and News

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NEXI Price Action

Trailing 12 Months

-100%

NEXI RSI Chart

NEXI Valuation

NEXI Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NEXI Fundamentals

NEXI Earnings

NEXI Profitability

NEXI Investor Care

Revenue & Growth

About NexImmune, Inc.

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

CEO	Ms. Kristi Jones R.Ph.
WEBSITE	neximmune.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	50

NexImmune, Inc. Frequently Asked Questions

What is the ticker symbol for NexImmune, Inc.? What does NEXI stand for in stocks?

NEXI is the stock ticker symbol of NexImmune, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NexImmune, Inc. (NEXI)?

As of Fri Nov 28 2025, market cap of NexImmune, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NEXI stock?

You can check NEXI's fair value in chart for subscribers.

Is NexImmune, Inc. a good stock to buy?

The fair value guage provides a quick view whether NEXI is over valued or under valued. Whether NexImmune, Inc. is cheap or expensive depends on the assumptions which impact NexImmune, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEXI.